RxDoctor Payments Data

Samuel Simha

Obstetrics & Gynecology · Memphis, TNNPI 1255304143

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,500 of the $1,518 with a category attached, or 98.8%. AbbVie accounts for 98.8% of it on its own, with 1 other manufacturer making up the rest.

$1,518in general payments, 2019–2025

Across 3 payments — averaging $505.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$18
$534,630in research payments, 2019–2025

Across 187 payments — averaging $2858.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$386K
  • Exeltis, USA Inc.$73K
  • Ventana Medical Systems, Inc.$50K
  • Myovant Sciences GmbH$15K
  • Myovant Sciences Inc.$6K
  • Sumitomo Pharma America, Inc.$4K

What the payments were for

  • Consulting fees$1,50099%
  • Food & beverage$181%

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie2$1,500
Novo Nordisk1$18

How this compares

$1,518 in reported general payments places this provider in the 60th percentile of 763 obstetrics & gynecology providers in Tennessee.

See all obstetrics & gynecology providers in Tennessee

Other obstetrics & gynecology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →